CD8+ T-cells, through their interaction with antigen presenting dendritic cells, exert their cytotoxic properties against cancer, while CD4+ cells can either contribute to CD8+ T-cell activation (T helper cells-Th) or, following differentiation from regulatory T-cells (Tregs), suppress CD8+ T-cell activity. This evidence concerns the gene CD4 and cancer.